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Abstract
 
Somatic hypermutation and isotype switch recombination occur in germinal center B cells, are
linked to transcription, and are similarly affected by deficiency in MutS homologue (MSH)2.
Class-switch recombination is abrogated by disruption of genes encoding components of the
catalytic subunit of DNA-dependent protein kinase (DNA-PK
 
cs
 
)/Ku complex and likely in-
volves nonhomologous end joining (NHEJ). That somatic hypermutation might also be associ-
ated with end joining is suggested by its association with the creation of deletions, duplications,
and sites accessible to terminal transferase. However, a requirement for NHEJ in the mutation
process has not been demonstrated. Here we show that somatic mutation in mice deficient in
NHEJ can be tested by introduction of rearranged immunoglobulin and T cell receptor trans-
genes: the transgene combination not only permits reconstitution of peripheral lymphoid com-
partments but also allows formation of germinal centers, despite the wholly monoclonal nature
of the lymphocyte antigen receptors in these animals. Using this strategy, we confirm that so-
matic hypermutation like class-switching can occur in the absence of recombination-activating
gene (RAG)1 but show that the two processes differ in that hypermutation can proceed essen-
tially unaffected by deficiency in DNA-PK
 
cs
 
 activity.
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Introduction
 
Three types of genetic transaction occur at the Ig gene loci
that play a role in antigen receptor diversification: V(D)J
joining, IgH class-switching, and somatic hypermutation.
The regulation of all three processes is in some way linked
to transcription. Although switching and hypermutation
are clearly distinct (they target different, albeit linked, re-
gions and each can take place independently of the other),
they show some striking parallels. Both are specific to the
secondary antibody repertoire and take place in germinal
center (GC) B cells; they preferentially act at similar con-
sensus sequences, and the efficiency and local target speci-
ficity of both processes is affected by deficiency in MutS
homologue (MSH)2 (1–5).
Here we focus on the role of nonhomologous end join-
ing (NHEJ). The absence of class-switching in B cells that
lack components of the catalytic subunit of DNA-depen-
dent protein kinase (DNA-PK
 
cs
 
)/Ku complex make it
highly likely that NHEJ is involved in switching (6–8). The
situation with regard to hypermutation is unknown. The
finding that hypermutation is accompanied by the creation
of sites accessible to terminal deoxynucleotidyl transferase
(TdT) in the V region (9) and that observations that hyper-
mutation can lead to deletions and duplications (in addition
to the physiological single nucleotide substitutions) (9–11)
could be interpreted as indicating a role for NHEJ in the
hypermutation process. Indeed, the ability of TdT to inter-
act with components of the DNA-PK
 
cs
 
/Ku complex (12,
13) could provide a mechanism for its recruitment to the
sites of DNA breaks. However, it is equally possible that
the breaks, duplications, and TdT-accessible sites are gen-
erated as byproducts of aberrant hypermutation events
without NHEJ constituting a necessary physiological inter-
mediate.
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Testing whether NHEJ is required for the somatic hy-
permutation of Ig genes cannot simply be accomplished by
analyzing hypermutation in mice defective in NHEJ, as
NHEJ is required to achieve successful antigen receptor as-
sembly and lymphocyte production. The same difficulty
similarly exists in testing whether the RAG proteins,
needed for the initiation of V(D)J joining, are also required
for hypermutation. To address this problem, we have de-
veloped a model in which the requirement for V(D)J re-
combination is bypassed through the provision of rear-
ranged Ig and TCR transgenes. We find that despite the
entirely monoclonal nature of both B and T cell compart-
ments, such mice can develop GCs in which hypermuta-
tion takes place. The results reveal that hypermutation can
proceed both in RAG1-deficient mice and SCID mice,
which lack a functional DNA-PK
 
cs
 
 (14, 15).
 
Materials and Methods
 
Mice.
 
MD4 mice (on a C57BL/6 background) (16) were ob-
tained from The Jackson Laboratory, and DO-TCR mice (on a
BALB/c background) (17) were from D. Loh (Washington Uni-
versity School of Medicine, St. Louis, MO). After rederivation
into our barriered facility, both lines were crossed with 
 
Scid/Scid
 
(14) or 
 
Rag1
 
2
 
/
 
2
 
 mice (18) on a C57BL/6 background to yield
animals of the required genotype. Mice were genotyped by PCR
of tail DNA (MD4: primers 5
 
9
 
-GCGACTCCATCACCAGC-
GAT and 5
 
9
 
-ACCACAGACCAGCAGGCAGA amplify across
the V
 
k
 
/J
 
k
 
 rearrangement [430-bp product] with inclusion of
5
 
9
 
-CTGGAGCCCTAGCCAAGGAT, allowing generation of a
control PCR product [264-bp product] from the germline J
 
k
 
locus; DO-TCR: primers 5
 
9
 
-TGGCTCTACAGTGAGTTTG-
GTGCCA and 5
 
9
 
-TGCAGCTGGATGGGATGAGCCAAGG
amplify the transgenic V
 
a
 
/J
 
a
 
 rearrangement [380-bp product];
RAG1: primers 5
 
9
 
-GGACATAGCGTTGGCTACCC [within
the inserted Neo cassette] and 5
 
9
 
-GAAAGGACTTCACT-
GGGCTCT [within RAG1] generate an 
 
z
 
650-bp product from
the targeted allele with the inclusion of AGATGTCTCAAAGT-
CATGGGC-3
 
9
 
 [within RAG1] that generates an 87-bp product
from the wild-type allele; SCID: primers 5
 
9
 
-GTCAGTCTCA-
TGTTGCCAATG and 5
 
9
 
-GTTGGCCCCTGCTAACTTTC
generate a 1,300-bp product, which is cut by AluI to yield 208-
and 18-bp fragments from the SCID allele and a 236-bp product
from the wild-type allele). A 214-bp BglII–HaeIII fragment of
the SCID PCR product from sorted GC B cells was cloned into
pBluescript for sequence analysis to confirm lack of reversion of
the SCID mutation.
 
FACS
 
®
 
 Analysis of Lymphocytes.
 
Splenic lymphocytes puri-
fied on Lympholyte-M (Cedarlane Laboratories Ltd.) were
stained with FITC-conjugated rabbit anti–mouse IgM and PE-
conjugated rat anti-CD45R(B220) (clone RA3-6B2; PharMin-
gen and Life Technologies) or PE-conjugated anti-CD4 and
FITC-conjugated anti-CD8 (PharMingen). The HyHEL10 id-
iotope was detected using mAb 7.6 (reference 19; obtained from
J.R. Drake, Trudeau Institute, Saranac Lake, NY) and FITC-
conjugated anti–mouse 
 
g
 
2a (PharMingen).
 
Immunohistology.
 
Peyer’s patches were quick-frozen in Tis-
sue-Tek OCT (Sakura) using liquid N
 
2
 
, and sections (6–8 
 
m
 
M)
were prepared using a microtome cryostat. After fixing in cold
acetone (10 min) and air drying, sections were stained with rat
anti-CD45R(B220), FITC-conjugated peanut agglutinin (PNA;
Vector Laboratories), or rabbit anti-Ki67 (Dianova). Sections
were developed with biotinylated anti–rabbit or anti–rat Ig (Jack-
son ImmunoResearch Laboratories) and alkaline phosphatase
conjugated to streptavidin or anti-FITC–Ig (Roche).
 
Analysis of Somatic Mutation.
 
DNA was prepared using a
QIAGEN minikit from GC B cells sorted from Peyer’s patches
on the basis of their PNA
 
hi
 
CD45R(B220)
 
1
 
 phenotype. The
transgenic V
 
k
 
 was amplified in a 30-cycle PCR using PfuTurbo
polymerase (Stratagene) and primers 5
 
9
 
-CAGCTCGAGAT-
TGTGCTAACTCAGTCTCC and 5
 
9
 
-CAGAGATCTACAC-
CTGATCTGAGAATGGA (452-nucleotide product) and cloned
into Bluescript for sequencing; primers 5
 
9
 
-CAGGGTACCCG-
AAGATGGTTTTCACACCT and 5
 
9
 
-CAGGAGCTCGTCC-
CATCACTGAATGTGAT yielded an 897-bp product that in-
cluded the transgenic V
 
k
 
 and additional intronic J
 
k
 
 3
 
9 
 
flank.
Sequence databases were corrected for germline differences be-
tween V
 
k
 
 transgene copies as well as any effects of clonality be-
fore computation of mutations as previously described (9). The
genotype of the mouse was confirmed in all studies by PCR anal-
ysis of DNA prepared from the PNA
 
lo
 
 population performed as
described for the tail DNA.
Figure 1. Somatic mutation of the Vk transgene in MD4 mice. (A) Se-
quences of the four distinct transgenic rearranged Vk domains that are de-
duced to exist in the germline of MD4 mice. The transgenic rearranged
Vk was PCR amplified from tail DNA and cloned into Bluescript. Of 33
clones sequenced, 5 derived from copy 0, 7 from copy 1, and 11 each
from copies 2 and 3. The copies are named according to the number of
nucleotide substitutions by which each diverges from the consensus se-
quence (copy 0). Nucleotide 1 corresponds to the first nucleotide of Ka-
bat codon 1. (B) Prevalence of somatic mutations in the four transgenic
Vk genes PCR amplified from sorted GC B cells from Peyer’s patches of
MD4 mice. The number in the center of the pie chart indicates the num-
ber of sequences contributing to each database, with the segments of the
pie indicating the number of sequences carrying 0, 1, 2, etc. mutations. 
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Results
 
Our strategy for analyzing hypermutation in mice carry-
ing genetic deficiencies rendering them incapable of pro-
ductive antigen receptor assembly was to reconstitute the B
and T cell compartments in these mice using Ig and TCR
transgenes, hoping that such genetically reconstituted mice
expressing monoclonal B and T cell antigen receptors
could nevertheless form GCs.
 
Multiple Transgene Copies in MD4 Mice All Act as Hyper-
mutation Targets.
 
MD4 mice, which carry an IgM–IgD,
 
k
 
transgene specific for hen egg lysozyme (16), were used to
provide the Ig transgene. As not all Ig transgenes are capa-
ble of acting as hypermutation targets (possibly reflecting a
sensitivity to integration site), we first checked that the
transgenic V
 
k
 
, PCR-amplified from the Peyer’s patch GC
B cells, had indeed been subjected to hypermutation. The
MD4 V
 
k
 
 sequences revealed an abundance of somatic mu-
tations (Fig. 1). However, in addition to the scattered mu-
tations characteristic of antibody hypermutation, some re-
current mutations were identified that were common to
samples obtained from different individual MD4 animals.
These recurrent mutations could be most readily explained
by postulating that the MD4 mice carry multiple 
 
k
 
 trans-
gene copies that differ in the germline by virtue of muta-
tions in the V
 
k
 
 domain. This explanation was confirmed by
sequencing the transgenic V
 
k
 
 from tail DNA. Thus, MD4
mice carry four distinct HyHEL10 V
 
k
 
 transgenes (differing
Figure 2. Reconstitution of peripheral lymphocyte compartments in MD4/DO-TCR(Rag12/2) and MD4/DO-TCR(Scid/Scid) mice. (A and B)
Flow cytometric analyses of splenic lymphocytes double stained for CD45R(B220) and IgM, CD4 and CD8, and CD45R(B220) and the HyHEL10 id-
iotype as indicated. (C) Reconstitution of Peyer’s patches. Peyer’s patches were classified as very small, small, or normal (light gray, dark gray, and black
bars, respectively), and the histogram depicts the average number of each size (based on four to six mice per group). (D) Immunohistological examination
of Peyer’s patches from an MD4/DO-TCR(Rag12/2) mouse (left) and an MD4(Rag12/2) mouse (right). Sequential sections have been stained for
CD45R(B220), PNA, and Ki67 (a marker of proliferating cells). GCs (which were also found to stain for FDC markers; not shown) can be seen as small
PNA1Ki671 clusters within the B cell follicles (marked B) of MD4/DO-TCR(Rag12/2) but not MD4(Rag12/2) mice, as indicated by arrowheads. 
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by 0, 1, 2, or 3 mutations from the canonical sequence); all
four copies act as efficient hypermutation targets.
The differences between the germline Ig
 
k
 
 transgene
copies could reflect mutations that were artificially intro-
duced during the in vitro manipulations of the transgene
DNA construct before creation of the MD4 mice. Alterna-
tively, they could have arisen during replication/recombi-
nation in vivo, possibly before transgene integration into
the chromosome.
 
GC Formation in Reconstituted Rag1
 
2
 
/
 
2
 
 and SCID Mice
Monoclonal for B and T Cell Antigen Receptors.
 
Crossing of
the MD4 transgene into a RAG1-deficient or SCID back-
ground allowed reconstitution of a peripheral B cell com-
partment as well as the development of Peyer’s patches
(Fig. 2, A–C). Additional provision of the DO11.10 
 
a
 
/
 
b
 
TCR transgene (specific for OVA323–329 in the context
of IA
 
d
 
; reference 17) allowed T cell reconstitution, trigger-
ing the development of both CD4
 
1
 
 and CD8
 
1
 
 subsets. We
wondered whether a GC reaction could be induced in the
reconstituted mice despite the fact that both B and T cells
expressed a solitary antigen receptor specificity with, pre-
sumably, a consequently limited range of antigen respon-
siveness. Histological examination of Peyer’s patches re-
vealed that GCs were present in essentially all of the
sections analyzed from 5 mo normal or MD4/DO-
TCR(
 
Rag1
 
1
 
/
 
1
 
) transgenic mice with an average of 0.8
GCs per B cell cluster and individual animals exhibiting a
range of 0.5–1.0 GCs/clusters. In the MD4/DO-TCR-
reconstituted 
 
Rag1
 
2
 
/
 
2
 
 and SCID mice, GCs could also de-
velop, although at lower frequency: on average there were
0.3 GCs per B cell cluster but with a range extending from
0 to 1.0 GCs per cluster (Fig. 2 D). These clusters of PNA
 
hi
 
cells detected in the Peyer’s patches of the reconstituted
mice were usually smaller than those in control animals.
No GCs were detected in the B cell clusters of 
 
Rag1
 
2
 
/
 
2
 
mice that had been reconstituted with the MD4 transgene
alone (Fig. 2 D, right).
 
Somatic Hypermutation in the Absence of RAG1 or Active
DNA-PK
 
cs
 
.
 
GC B cells from the Peyer’s patches of
MD4/DO-TCR(
 
Rag1
 
2
 
/
 
2
 
) mice were sorted by virtue of
their CD45R(B220)
 
1
 
PNA
 
hi
 
 phenotype. Sequence analysis
of the PCR-amplified transgenic V
 
k
 
 segments revealed
that the V
 
k
 
 transgenes had accumulated multiple somatic
mutations, and there was no clear difference in the extent
of transgene mutation in the B cells from RAG1-deficient
and RAG1-proficient mice, as judged by the average num-
ber of mutations per mutated sequence, the distribution of
mutations across the mutation domain, the transition bias,
or the G/C to A/T ratio (Fig. 3 and Table I).
A similar approach to the analysis of mutations in SCID
mice also revealed abundant somatic mutations. Again,
analysis of the distribution of mutations over the V
 
k
 
 do-
main and its 3
 
9 
 
flank as well as of the nucleotide substitu-
tion preferences does not reveal any major divergence from
the pattern of somatic mutation in normal mice, although
the proportion of mutations at GC base pairs is increased
from 44% in normal (or RAG1-deficient) mice to 57% in
MD4/DO-TCR(SCID) mice (Fig. 4, A and C; Table I). It
is interesting that deletions, which have previously been
proposed to be generated by somatic hypermutation in hu-
man B cells (9–11), also occasionally accompany somatic
Figure 3. Somatic mutation of
the Vk transgene in MD4/DO-
TCR(Rag12/2) mice. (A) Se-
quence diversity due to somatic
mutation of the transgenic Vk
PCR amplified from sorted GC
B cells from Peyer’s patches of
MD4/DO-TCR(Rag12/2) mice.
The mutations identified in sam-
ples obtained from five mice (an-
alyzed in two pools) have been
combined. (B) Comparison of
the distribution of mutations
across the Vk domain in MD4
(above the line) and MD4/
DO-TCR(Rag12/2) mice (be-
low the line).
Table I. Nucleotide Substitution Preferences
To
From Background T C G A Total
T Normal – 8.3 4.0 4.0 16
Rag12/2 – 4.3 0.9 6.0 11
SCID – 5.2 2.8 3.2 11
C Normal 15 – 4.6 3.3 22
Rag12/2 14 – 2.5 5.0 21
SCID 2.3 – 4.0 16 23
G Normal 2.5 6.0 – 13 22
Rag12/2 5.3 2.1 – 16 23
SCID 2.9 7.9 – 23 34
A Normal 12 7.0 19 – 38
Rag12/2 8.7 9.5 25 – 43
SCID 12 6.5 14 – 33
Single nucleotide substitutions on the Vk sense strand are expressed as a
percentage of the total number of mutations identified and have been
corrected for base composition of the target. Database statistics are as
follows: Normal, 303 mutations (none clonally related) in 118 sequences
with 50 mutated sequences giving 6.1 mutations per mutated sequence;
Rag12/2, 108 mutations (6 clonally related) in 60 sequences with 21
mutated sequences giving 5.1 mutations per mutated sequence; SCID,
267 mutations (48 clonally related) in 95 sequences with 55 mutated
sequences giving 4.9 mutations per mutated sequence.1513 Bemark et al. Brief Definitive Report
hypermutation in mice even in the absence of DNA-PKcs
(Fig. 4 B).
We were careful to exclude the possibility that the GCs
in MD4/DO-TCR(SCID) mice were not simply popu-
lated by DNA-PKcs
1 revertant founder B cells, which were
then able to expand and undergo hypermutation owing to
their DNA-PK1 phenotype. We therefore amplified the
relevant portion of the DNA-PKcs gene from DNA ex-
tracted from two distinct pools of sorted CD45R
(B220)1PNAhi B cells from MD4/DO-TCR(SCID) mice
that had also been used for Vk mutation analysis and had
revealed abundant Vk somatic mutation. Sequence analysis
revealed no case of reversion of the TAA-406 stop codon
(or indeed any other mutation) out of 16 templates se-
quenced. Thus, somatic hypermutation can clearly occur in
SCID B cells.
Discussion
GCs are found within the Peyer’s patches of MD4/DO-
TCR(Rag12/2) and MD4/DO-TCR(SCID) mice. This
presumably means that, despite the monoclonal nature of
both B and T cell receptors in these animals, there are en-
vironmental antigens in the gut that yield both B and T cell
epitopes of sufficient affinity to allow activation and pro-
ductive interaction of the MD4-BCR–expressing B cells
with DO-TCR T cells. The same strategy used here could
therefore be extrapolated to monitor somatic hypermuta-
tion in other mutant mice incapable of productive antigen
receptor assembly (e.g., Ku70- and Ku80-deficient mice).
Deficiency in RAG1 has no apparent effect on the ex-
tent or pattern of mutation. That hypermutation can pro-
ceed without RAG1 is not unanticipated in view of previ-
ous observations referred to by Zheng et al. (20) using
lymphocyte-repopulated animals. However, that mutation
can proceed in genetically reconstituted SCID mice is, to
our knowledge, the first identification of a gene product
involved in DNA metabolism that is differentially required
for class-switching and somatic hypermutation.
The ability of hypermutation to proceed essentially unaf-
fected as regards both extent and pattern in the absence of
an active DNA-PKcs makes it improbable that NHEJ is re-
quired for hypermutation. Rather, it is likely that double-
strand DNA breaks are either not necessary intermediates
in the hypermutation process, or, if they are, that such
breaks are resolved (as in homologous recombination) by
templating on the sister chromatid during the G2/S phase
of the cell cycle with such template-dependent DNA syn-
thesis possibly being error prone.
We thank Theresa Langford for help with animal handling and An-
drew Johnson for flow cytometry. 
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